GlassScriptPhysician profile
Mina A Salib
NPI 1528365277
$1,710.45
in general payments reported to CMS, 2019-2025
15 companies · $482 in 2025
The $482 reported for 2025 was more than what 85% of Pediatric Critical Care Medicine providers received nationally (typical 2025 total: $71.68).
See the full distribution for Pediatric Critical Care Medicine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.14 · 2021: $78.24 · 2022: $85.64 · 2023: $445 · 2024: $606 · 2025: $482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,400 · Education: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,400.44 |
| Education | $132.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $502.32 | 2022-2024 | Fasenra, Tezspire |
| Genzyme Corporation | $326.52 | 2022-2025 | |
| Glaxosmithkline, LLC. | $154.33 | 2019-2025 | Nucala |
| Abbott Laboratories | $153.76 | 2021-2023 | Proclaim |
| Alcresta Therapeutics, INC. | $150.00 | 2025 | Relizorb |
| Sanofi-Aventis U.S. LLC | $98.99 | 2025 | |
| Insmed, INC. | $77.96 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $44.01 | 2023-2024 | Dupixent |
| Chiesi USA, INC. | $37.54 | 2022-2023 | Bronchitol |
| Amgen INC. | $34.00 | 2025 | |
| Alk-Abello, INC | $32.66 | 2022-2023 | Alternaria Tenuis, Timothy, Standardized, Standardized Mite D. Farinae |
| Novartis Pharmaceuticals Corporation | $31.14 | 2024-2025 | |
| Vertex Pharmaceuticals Incorporated | $30.92 | 2022-2024 | |
| Nestle Healthcare Nutrition INC. | $20.23 | 2023 | |
| Sobi, INC | $16.07 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mina Salib listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.